JP2019026583A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019026583A5 JP2019026583A5 JP2017146374A JP2017146374A JP2019026583A5 JP 2019026583 A5 JP2019026583 A5 JP 2019026583A5 JP 2017146374 A JP2017146374 A JP 2017146374A JP 2017146374 A JP2017146374 A JP 2017146374A JP 2019026583 A5 JP2019026583 A5 JP 2019026583A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Description
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017146374A JP6945377B2 (ja) | 2017-07-28 | 2017-07-28 | エルロチニブを有効成分とする医薬錠剤及びその製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017146374A JP6945377B2 (ja) | 2017-07-28 | 2017-07-28 | エルロチニブを有効成分とする医薬錠剤及びその製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019026583A JP2019026583A (ja) | 2019-02-21 |
| JP2019026583A5 true JP2019026583A5 (ja) | 2020-05-21 |
| JP6945377B2 JP6945377B2 (ja) | 2021-10-06 |
Family
ID=65475681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017146374A Active JP6945377B2 (ja) | 2017-07-28 | 2017-07-28 | エルロチニブを有効成分とする医薬錠剤及びその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6945377B2 (ja) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2801349A1 (en) * | 2013-05-06 | 2014-11-12 | Siegfried AG | Oral Pharmaceutical Formulation |
| US20150065526A1 (en) * | 2013-09-05 | 2015-03-05 | Emory University | Overcoming acquired resistance to chemotherapy treatments through suppression of stat3 |
-
2017
- 2017-07-28 JP JP2017146374A patent/JP6945377B2/ja active Active